Arthur Kowaloff - Dentsply Sirona Director

XRAY Stock  USD 30.44  0.08  0.26%   

Director

Mr. Arthur D. Kowaloff is an Independent Director of the Company. From 2014 to the present, Mr. Kowaloff has served as a director of United States Enrichment Corporationration a wholly owned subsidiary of Centrus Energy. In 2014 and 2015, Mr. Kowaloff served as a director of Reichhold Chemicals, Inc. and from 2010 until 2012, he served as lead director of Metropolitan Health Networks, Inc. From 1998 to 2003, Mr. Kowaloff served as a Managing Director of BNY Capital Markets, Inc. From 1991 to 1998, he was Chief Operating Officer and Senior Managing Director of Patricof Company Capital Corporationrationration. Prior to that, Mr. Kowaloff was an attorney at the New York City firm of Willkie Farr Gallagher, where he served as Senior Partner and Executive Committee Member and specialized in corporate and securities law and mergers and acquisitions. Mr. Kowaloff is currently the President and a Director of the PBP Foundation of New York. since 2016.
Age 71
Tenure 8 years
Address 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607
Phone844 848 0137
Webhttps://www.dentsplysirona.com
Kowaloff received a B.A. from Carleton College and holds a Juris Doctor degree from Yale Law S

Dentsply Sirona Management Efficiency

The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0372) %, meaning that it created substantial loss on money invested by shareholders. Dentsply Sirona's management efficiency ratios could be used to measure how well Dentsply Sirona manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.04 in 2024. Return On Capital Employed is likely to drop to 0.05 in 2024. At this time, Dentsply Sirona's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 271.9 M in 2024, whereas Total Assets are likely to drop slightly above 3.7 B in 2024.
The company currently holds 2.3 B in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. Dentsply Sirona has a current ratio of 1.47, which is within standard range for the sector. Debt can assist Dentsply Sirona until it has trouble settling it off, either with new capital or with free cash flow. So, Dentsply Sirona's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dentsply Sirona sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dentsply to invest in growth at high rates of return. When we think about Dentsply Sirona's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Deborah KochevarCharles River Laboratories
64
Laurie GlimcherWaters
66
Richard ReeseCharles River Laboratories
75
Susan SiegelIllumina
57
Connie HarveyMettler Toledo International
52
Judy LewentThermo Fisher Scientific
71
James MullenThermo Fisher Scientific
62
Daniel PodolskyAgilent Technologies
67
George MilneCharles River Laboratories
77
Nancy AndrewsCharles River Laboratories
63
Richard WallmanCharles River Laboratories
69
Debora SparThermo Fisher Scientific
56
Paul ClarkAgilent Technologies
72
George ScangosAgilent Technologies
72
Francis deSouzaIllumina
53
Constance HarveyMettler Toledo International
56
Heidi FieldsAgilent Technologies
60
William ParrettThermo Fisher Scientific
71
Dipchand NisharGuardant Health
N/A
Joshua BekensteinWaters
56
Lars SorensenThermo Fisher Scientific
67
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company was founded in 1877 and is headquartered in Charlotte, North Carolina. Dentsply Sirona operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15000 people. Dentsply Sirona (XRAY) is traded on NASDAQ Exchange in USA. It is located in 13320-B Ballantyne Corporate Place, Charlotte, NC, United States, 28277-3607 and employs 15,000 people. Dentsply Sirona is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Dentsply Sirona Leadership Team

Elected by the shareholders, the Dentsply Sirona's board of directors comprises two types of representatives: Dentsply Sirona inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dentsply. The board's role is to monitor Dentsply Sirona's management team and ensure that shareholders' interests are well served. Dentsply Sirona's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dentsply Sirona's outside directors are responsible for providing unbiased perspectives on the board's policies.
Maureen MacInnis, Chief Human Resource Officer, Senior Vice President
Dan Workinger, Treasurer
Thomas Jetter, Lead Director, Independent Director
Paula Cholmondeley, Independent Director
Lisa Yankie, VP Officer
Francis Lunger, Independent Director
Andrew Robinson, VP Officer
Kevin Boyle, Senior Officer
Christopher Clark, Pres and CFO
Deborah Rasin, Vice President General Counsel, Secretary
Betsy Holden, Director
Donald Casey, CEO, Director
Derek Leckow, VP, Investor Relations
Andreas Frank, Executive Officer
Nicholas Alexos, Executive Vice President Chief Administrative Officer
Daniel Key, Senior Vice President Chief Supply Chain Officer
Justin McCarthy, General Counsel, Secretary
Albert Sterkenburg, Senior Vice President
Markus Boehringer, Senior Vice President - EMEA RCO
Erania Brackett, SVP Sustainability
Walter Petersohn, Senior Vice President Chief Commercial Officer
William Hecht, Lead Independent Director
Jonathan Friedman, Senior Vice President General Counsel, Secretary
Mark Thierer, Interim CEO
Cord Staehler, VP CTO
Bret Wise, Chairman, CEO and Chairman of Executive Committee
Glenn Coleman, Executive CFO
Henning Mueller, Group Vice President - Asia Pacific RCO
Ulrich Michel, CFO, Executive Vice President
Rainer Berthan, Executive Vice President Manufacturing and Supply Chain
Richard Wagner, Chief Officer
Cheree Johnson, Chief VP
Dane Baumgardner, AttorneyInFact
John Sweeney, vice president IR Contact Officer
Eric Bruno, Senior Vice President - North America Regional Commercial Organization
Jorge Gomez, CFO, Executive Vice President
Andrea Daley, Vice Relations
Robert Size, Sr. VP
Harry Kraemer, Director
Andrea Frohning, Senior Officer
Michael Coleman, Independent Director
David Beecken, Director
Leslie Varon, Director
Eric Brandt, Independent Director
Robert Johnson, Senior Officer
William Newell, Senior Vice President Chief Segment Officer
Willie Deese, Independent Director
Simon Campion, President CEO
Keith Ebling, Executive Vice President General Counsel, Secretary
John Miles, Independent Director
Richard Rosenzweig, General Development
Michael Alfano, Independent Director
James Mosch, COO and Executive VP
Emily Miner, Senior Officer
John Miclot, Independent Director
Arthur Kowaloff, Director
Jeffrey Slovin, CEO, Director

Dentsply Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Dentsply Sirona a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Dentsply Sirona Investors Sentiment

The influence of Dentsply Sirona's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dentsply. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dentsply Sirona's public news can be used to forecast risks associated with an investment in Dentsply. The trend in average sentiment can be used to explain how an investor holding Dentsply can time the market purely based on public headlines and social activities around Dentsply Sirona. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dentsply Sirona's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dentsply Sirona's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dentsply Sirona's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dentsply Sirona.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dentsply Sirona in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dentsply Sirona's short interest history, or implied volatility extrapolated from Dentsply Sirona options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Dentsply Sirona offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dentsply Sirona's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dentsply Sirona Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dentsply Sirona Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Dentsply Sirona. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Dentsply Stock please use our How to Invest in Dentsply Sirona guide.
Note that the Dentsply Sirona information on this page should be used as a complementary analysis to other Dentsply Sirona's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Dentsply Stock analysis

When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is Dentsply Sirona's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dentsply Sirona. If investors know Dentsply will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dentsply Sirona listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.178
Dividend Share
0.56
Earnings Share
(0.62)
Revenue Per Share
18.703
Quarterly Revenue Growth
0.03
The market value of Dentsply Sirona is measured differently than its book value, which is the value of Dentsply that is recorded on the company's balance sheet. Investors also form their own opinion of Dentsply Sirona's value that differs from its market value or its book value, called intrinsic value, which is Dentsply Sirona's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dentsply Sirona's market value can be influenced by many factors that don't directly affect Dentsply Sirona's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dentsply Sirona's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dentsply Sirona is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dentsply Sirona's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.